Skip to content

NMC Health controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile4 entries

  1. 2023

    Financial Conduct Authority market-abuse censure

    The FCA censured NMC Health for market abuse involving debt understatement of as much as US$4 billion. No fine was imposed because the insolvent company was not expected to have funds available after creditor payments.

  2. 2020

    Undisclosed financing facilities and insolvency

    NMC disclosed more than US$2.7 billion of previously unreported financing facilities. The resulting liquidity and governance crisis contributed to share suspension, creditor actions and UK administration.

  3. 2020

    UK accounting regulator investigates EY over NMC Health audits

    Investigation

    The UK accounting regulator opened an investigation into EY concerning its audit of NMC Health. The source does not state when the investigation was opened. The event is recorded as a controversy note in the Brand Wiki, summarizing only the fact of the investigation and the identity of the audit firm involved. No findings, penalties, or conclusions are attributed to EY or NMC Health in the source material used for this note. The note is limited to the information provided and does not add further details about the scope, timing, or outcome of the investigation.

    Source excerpt

    • The UK accounting regulator has revealed it has opened an investigation into EY over its audit of troubled healthcare firm NMC Health, which tumbled into administration last month.
  4. 2019

    Alleged understatement of debt

    Muddy Waters alleged that NMC Health had manipulated its balance sheet and understated debt. The allegations triggered a broader review of the company's accounts and financing arrangements.